Genetic Variation in the SLC8A1 Calcium Signaling Pathway Is Associated With Susceptibility to Kawasaki Disease and Coronary Artery Abnormalities

Background—Kawasaki disease (KD) is an acute pediatric vasculitis in which host genetics influence both susceptibility to KD and the formation of coronary artery aneurysms. Variants discovered by genome-wide association studies and linkage studies only partially explain the influence of genetics on KD susceptibility. Methods and Results—To search for additional functional genetic variation, we performed pathway and gene stability analysis on a genome-wide association study data set. Pathway analysis using European genome-wide association study data identified 100 significantly associated pathways (P<5×10−4). Gene stability selection identified 116 single nucleotide polymorphisms in 26 genes that were responsible for driving the pathway associations, and gene ontology analysis demonstrated enrichment for calcium transport (P=1.05×10−4). Three single nucleotide polymorphisms in solute carrier family 8, member 1 (SLC8A1), a sodium/calcium exchanger encoding NCX1, were validated in an independent Japanese genome-wide association study data set (meta-analysis P=0.0001). Patients homozygous for the A (risk) allele of rs13017968 had higher rates of coronary artery abnormalities (P=0.029). NCX1, the protein encoded by SLC8A1, was expressed in spindle-shaped and inflammatory cells in the aneurysm wall. Increased intracellular calcium mobilization was observed in B cell lines from healthy controls carrying the risk allele. Conclusions—Pathway-based association analysis followed by gene stability selection proved to be a valuable tool for identifying risk alleles in a rare disease with complex genetics. The role of SLC8A1 polymorphisms in altering calcium flux in cells that mediate coronary artery damage in KD suggests that this pathway may be a therapeutic target and supports the study of calcineurin inhibitors in acute KD.

[1]  P. Donnelly,et al.  A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association Studies , 2009, PLoS genetics.

[2]  P. Hegyi,et al.  Na+/Ca2+ exchangers regulate the migration and proliferation of human gastric myofibroblasts. , 2013, American journal of physiology. Gastrointestinal and liver physiology.

[3]  S. Shaughnessy,et al.  Do No Harm: Health Systems’ Duty to Promote Clinician Well-Being , 2022, American Journal of Hospital Medicine.

[4]  H. Rahamimoff,et al.  Cyclosporin A‐Dependent Downregulation of the Na+/Ca2+ Exchanger Expression , 2007, Annals of the New York Academy of Sciences.

[5]  Yoshihiro Onouchi,et al.  Genetics of Kawasaki disease: what we know and don't know. , 2012, Circulation journal : official journal of the Japanese Circulation Society.

[6]  Yusuke Nakamura,et al.  ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms , 2008, Nature Genetics.

[7]  Yu-guang Li,et al.  Urotensin II induces phenotypic differentiation, migration, and collagen synthesis of adventitial fibroblasts from rat aorta , 2008, Journal of hypertension.

[8]  M. Triggiani,et al.  Expression and function of Na+/Ca2+ exchangers 1 and 3 in human macrophages and monocytes , 2009, European journal of immunology.

[9]  H. Krum,et al.  Chronic urotensin-II infusion induces diastolic dysfunction and enhances collagen production in rats. , 2010, American journal of physiology. Heart and circulatory physiology.

[10]  P. Conlin,et al.  Na+/Ca2+ Exchanger Activity Modulates Connective Tissue Growth Factor mRNA Expression in Transforming Growth Factor β1- and Des-Arg10-kallidin-stimulated Myofibroblasts* , 2005, Journal of Biological Chemistry.

[11]  Tien Yin Wong,et al.  Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease , 2011, Nature Genetics.

[12]  J. Burns,et al.  Galectin-3 is a marker of myocardial and vascular fibrosis in Kawasaki disease patients with giant aneurysms. , 2015, International journal of cardiology.

[13]  A. Tremoulet The role of statins in inflammatory vasculitides , 2015, Autoimmunity.

[14]  Kei Takahashi,et al.  Neutrophilic involvement in the damage to coronary arteries in acute stage of Kawasaki disease , 2005, Pediatrics international : official journal of the Japan Pediatric Society.

[15]  A. Hata,et al.  Cyclosporin A Treatment for Kawasaki Disease Refractory to Initial and Additional Intravenous Immunoglobulin , 2011, The Pediatric infectious disease journal.

[16]  J. Kimura,et al.  Lysophosphatidylcholine increases Na+/Ca2+ exchanger expression via RhoB-geranylgeranylation in H9c2 cells. , 2009, Journal of pharmacological sciences.

[17]  C. Aalkjær,et al.  Vascular smooth muscle cell phenotype is defined by Ca2+‐dependent transcription factors , 2013, The FEBS journal.

[18]  M. Berridge,et al.  Calcium: Calcium signalling: dynamics, homeostasis and remodelling , 2003, Nature Reviews Molecular Cell Biology.

[19]  J. Orenstein,et al.  Three Linked Vasculopathic Processes Characterize Kawasaki Disease: A Light and Transmission Electron Microscopic Study , 2012, PloS one.

[20]  Scott Mellis,et al.  Transforming Growth Factor-&bgr; Signaling Pathway in Patients With Kawasaki Disease , 2011, Circulation. Cardiovascular genetics.

[21]  Hariklia Eleftherohorinou,et al.  Pathway-driven gene stability selection of two rheumatoid arthritis GWAS identifies and validates new susceptibility genes in receptor mediated signalling pathways. , 2011, Human molecular genetics.

[22]  Libiao Wu,et al.  Transforming growth factor-β1 involved in urotensin II-induced phenotypic differentiation of adventitial fibroblasts from rat aorta. , 2010, Chinese medical journal.

[23]  J. Burns,et al.  The role of TGF-β and myofibroblasts in the arteritis of Kawasaki disease. , 2013, Human pathology.

[24]  Toshihiro Tanaka,et al.  Variations in ORAI1 Gene Associated with Kawasaki Disease , 2016, PloS one.

[25]  A. Hata,et al.  Study protocol for a phase III multicentre, randomised, open-label, blinded-end point trial to evaluate the efficacy and safety of immunoglobulin plus cyclosporin A in patients with severe Kawasaki disease (KAICA Trial) , 2015, BMJ Open.

[26]  J. Kimura,et al.  Involvement of Na+/Ca2+ exchanger in migration and contraction of rat cultured tendon fibroblasts , 2009, The Journal of physiology.

[27]  Y. S. Cho,et al.  A common variant in SLC8A1 is associated with the duration of the electrocardiographic QT interval. , 2012, American journal of human genetics.

[28]  Yun‐Min Zheng,et al.  Sodium–Calcium Exchanger in Pulmonary Artery Smooth Muscle Cells , 2007, Annals of the New York Academy of Sciences.

[29]  R. Uehara,et al.  Epidemiology of Kawasaki Disease in Asia, Europe, and the United States , 2012, Journal of epidemiology.

[30]  C. Hoggart,et al.  Pathway Analysis of GWAS Provides New Insights into Genetic Susceptibility to 3 Inflammatory Diseases , 2009, PloS one.

[31]  J. Newburger,et al.  Resistance to intravenous immunoglobulin in children with Kawasaki disease. , 2008, The Journal of pediatrics.

[32]  Ross M. Fraser,et al.  A General Approach for Haplotype Phasing across the Full Spectrum of Relatedness , 2014, PLoS genetics.

[33]  J. Newburger,et al.  Coronary artery outcomes among children with Kawasaki disease in the United States and Japan. , 2013, International journal of cardiology.

[34]  C. Khor,et al.  Global gene expression profiling identifies new therapeutic targets in acute Kawasaki disease , 2014, Genome Medicine.

[35]  Paul D. Mitchell,et al.  Coronary Artery Involvement in Children With Kawasaki Disease: Risk Factors From Analysis of Serial Normalized Measurements , 2007, Circulation.

[36]  J. Kimura,et al.  Down-Regulation of Na+/Ca2+ Exchanger by Fluvastatin in Rat Cardiomyoblast H9c2 Cells: Involvement of RhoB in Na+/Ca2+ Exchanger mRNA Stability , 2005, Molecular Pharmacology.

[37]  Yusuke Nakamura,et al.  A genome-wide association study identifies three new risk loci for Kawasaki disease , 2012, Nature Genetics.

[38]  B. Quednau,et al.  Tissue specificity and alternative splicing of the Na+/Ca2+ exchanger isoforms NCX1, NCX2, and NCX3 in rat. , 1997, The American journal of physiology.

[39]  P. Pacaud,et al.  Urotensin II is a New Chemotactic Factor for UT Receptor-Expressing Monocytes1 , 2007, The Journal of Immunology.

[40]  K. Yabuta,et al.  Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-gamma in Kawasaki disease involved coronary-artery lesions. , 1990, Clinical immunology and immunopathology.